RAD51 and cancer: Abnormalities in DNA repair and genomic instability, including HDR deficiency, represent a key hallmark of cancer and constitute one of the most common drivers of tumorigenesis [45]; thus, understanding the 3E10-RAD51 interaction is imperative for the advancement of this mAb toward the most effective therapy for the large cohort of patients with DNA-repair deficient tumors.